Stefania Fagagnini
MRI and PET-CT Failed to Differentiate Between Hepatic Malignancy and Brucelloma
Schreiber P, Mullhaupt B, Schiesser M, Boggian K, Reiner C, Vrugt B, Kröger A, Fagagnini S, Schmid A, Günthard H. MRI and PET-CT Failed to Differentiate Between Hepatic Malignancy and Brucelloma. Open Forum Infect Dis 2018; 5:ofy052.
08.03.2018MRI and PET-CT Failed to Differentiate Between Hepatic Malignancy and Brucelloma
08.03.2018Open Forum Infect Dis 2018; 5:ofy052
Schreiber Peter W, Mullhaupt Beat, Schiesser Marc, Boggian Katia, Reiner Cäcilia S, Vrugt Bart, Kröger Arne, Fagagnini Stefania, Schmid Adrian, Günthard Huldrych F
Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis
Jörger M, Wilkins J, Fagagnini S, Baldinger R, Brenneisen R, Schneider U, Goldman B, Weber M. Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis. Drug Metab Lett 2012; 6:102-8.
01.06.2012Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis
01.06.2012Drug Metab Lett 2012; 6:102-8
Jörger Markus, Wilkins Justin, Fagagnini Stefania, Baldinger Reto, Brenneisen Rudolf, Schneider Ursula, Goldman Bea, Weber Markus